Biotech caution

Despite investor interest in the biotechnology sector, analysts believe the market is still fickle and volatile and have warned caution. Since July, 14 new biotech-related companies have either listed on the ASX or are about to according to the Deloitte Biotech Index released this week.

‘Biotech market comes back full of life’, The Australian Financial Review, 26/10/00, p MW3.